NMDA-receptor antagonist requirements in conantokin-G

FEBS Letters

Volumn 435, Issue 2-3, 1998, Pages 257-262

  Blandl, Tamas ^a   Prorok, Mary ^a   Castellino, Francis J ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

Carboxyglutamate; Conantokin G; Ion channel; Metal binding; N Methyl D aspartate receptor; Polypeptide conformation

Indexed keywords

4 CARBOXYGLUTAMIC ACID; DIZOCILPINE; ION CHANNEL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; POLYPEPTIDE;

ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN MEMBRANE; CIRCULAR DICHROISM; CONTROLLED STUDY; METAL BINDING; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN CONFORMATION; RAT; STRUCTURE ACTIVITY RELATION;

AMINO ACID SUBSTITUTION; ANIMALS; BRAIN; CELL MEMBRANE; CONOTOXINS; EXCITATORY AMINO ACID ANTAGONISTS; ION CHANNELS; MOLLUSK VENOMS; PEPTIDES, CYCLIC; PROTEIN CONFORMATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0032544749     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(98)01077-1     Document Type: Article

References (23)

1. McIntosh J., Olivera B.M., Cruz L., Gray W. J. Biol. Chem. 259:1984;14343-14346.
2. Haack J.A., Rivier J., Parks T.N., Mena E.E., Cruz L.J., Olivera B.M. J. Biol. Chem. 265:1990;6025-6029.
3. Prorok M., Warder S.E., Blandl T., Castellino F.J. Biochemistry. 35:1996;16528-16534.
4. Blandl T., Zajicek J., Prorok M., Castellino F.J. Biochem. J. 328:1997;777-783.
5. Prorok, M. and Castellino, F.J. (1998) J. Biol. Chem. 273, in press.
6. Skjaerbaek N., Nielsen K.J., Lewis R.J., Alewood P., Craik D.J. J. Biol. Chem. 272:1997;2291-2299.
7. Chen Z.G., Blandl T., Prorok M., Warder S.E., Li L.P., Zhu Y., Pedersen L.G., Ni F., Castellino F.J. J. Biol. Chem. 273:1998;16248-16258.
8. Warder S.E., Prorok M., Chen Z.G., Li L.P., Zhu Y., Pedersen L.G., Ni F., Castellino F.J. J. Biol. Chem. 273:1998;7512-7522.
9. Warder S.E., Chen Z.G., Zhu Y., Prorok M., Castellino F.J., Ni F. FEBS Lett. 411:1997;19-26.
10. Jahr C.E., Stevens C.F. Nature. 325:1987;522-525.
11. Johnson J.W., Ascher P. Nature. 325:1987;529-531.
12. Rock D.M., MacDonald R.L. Mol. Pharmacol. 42:1992;157-164.
13. Mattson M.P., Rydel R.E., Lieberburg I., Smith-Swintosky V.L. Ann. NY Acad. Sci. 679:1993;1-21.
14. Marin C., Papa S., Engber T.M., Bonastre M., Tolosa E., Chase T.N. Brain Res. 736:1996;202-205.
15. Greenamyre J.T., Young A.B. Neurobiol. Aging. 10:1989;593-602.
16. Skolnick P., Boje K., Miller R., Pennington M., Maccecchini M.-L. J. Neurochem. 59:1992;1516-1521.
17. Mena E.E., Gullak M.F., Pagnozzi M.J., Richter K.E., Rivier J., Cruz L.J., Olivera B.M. Neurosci. Lett. 118:1990;241-244.
18. Hammerland L.G., Olivera B.M., Yoshikami D. Eur. J. Pharmacol. 226:1992;239-244.
19. Huang C.C., Lyu P.C., Lin C.H., Hsu K.S. Toxicon. 35:1997;355-363.
20. Zhou L.-M., Szendrei G.I., Fossom L.H., Maccaccheni M.-L., Skolnick P., Otvos L. J. Neurochem. 66:1996;620-628.
21. Colpitts T.L., Castellino F.J. Biochemistry. 33:1994;3501-3508.
22. Chen Y.-H., Yang J.T., Martinez H.M. Biochemistry. 11:1972;4120-4131.
23. Marvizon J.C., Baudry M. J. Neurochem. 63:1994;963-971.